Last reviewed · How we verify
NCT06735885
fMRI Neurofeedback With Matter Neuroscience App
NA trial testing Matter Neuroscience App in Depression Mild in 240 participants. Currently enrolling.
15 June 2027
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 240 |
| Start date | 12 August 2025 |
| Primary completion | 15 June 2027 |
| Estimated completion | 15 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Matter Neuroscience App
- Stock Photos
- No Home Training
- Personal Photos
- Home Training
Conditions studied
- Depression Mild — all drugs for Depression Mild →
- Depression — all drugs for Depression →
- Depression Moderate — all drugs for Depression Moderate →
Sponsor
Stanford University
Who can join
Adults 18 to 80, any sex, with Depression Mild or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06735885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression Mild
Currently open trials in the same condition.
- NCT06456931 — A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cogni · NA · recruiting
- NCT06374056 — Kintsugi Voice Device Pilot Study · active not recruiting
- NCT06273995 — Telehealth Behavioral Activation for Teens · NA · recruiting
- NCT05788198 — Integrated Depression Care · NA · recruiting
- NCT05267340 — Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2 · NA · active not recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06735885 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06735885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing